Tag: Diabetes
Latest article
Costly vitamin
The health burden caused by children and mothers has been largely ignored for years. When adolescent or reproductive-age girls are malnourished, they...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
